A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Quebec, New York NY, Saint-Charles-Borromee,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase2, Recruiting
A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
for
Haematologic Neoplasms
Location: Tampa FL, Houston TX
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07064122
Phase1, Recruiting
Tezspire Cardiac Events PASS
for
Cardiovascular Events, MACE
Location: Wilmington DE
Sponsor: AstraZeneca
Sex: All
Age: 12 - 70+
Code: NCT06951867
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
for
Breast Cancer
Location: New York NY, Fort Wayne IN, Omaha NE, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07205822
Phase3, Recruiting
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Boston MA, Providence RI, New York NY, Myrtle Beach SC,
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
for
Untreated Follicular Lymphoma
Location: Halifax, New Haven CT, Quebec, Chicoutimi, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06549595
Phase3, Recruiting
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
for
Prostate Cancer
Location: Providence RI, Quebec, Commack NY, Orlando FL, Tampa FL,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT07192614
Phase1, Phase2, Recruiting
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus